CLOCK and central nervous system cancer: To further explore whether similar transcriptomic subtypes based on clock gene expression can be observed in low-grade glioma patients, we examined an additional independent dataset comprised of gene expression profiles from (195) low-grade (2) glioma samples (166 IDH-mutant, and 14 IDH wild-type) from Gao and colleagues [36].